A new BMJ analysis has identified a critical transparency deficit in observational cohort studies that could compromise the integrity of medical evidence. While randomised controlled trials are mandated to register their protocols and primary outcomes, cohort studies examining interventions face virtually no such requirements—despite their growing role in clinical decision-making.
Cohort studies have become essential for evaluating interventions in populations where randomisation is impractical or unethical, including elderly patients, pregnant women, and other vulnerable groups. However, this methodological flexibility comes with a cost: without standardised registration requirements, researchers may selectively report outcomes, potentially biasing results and misleading clinical practice.
Experts emphasise that recent methodological advances have enhanced the reliability of well-conducted cohort studies, particularly those using target trial emulation. The research community must now establish registration standards that match these improvements, ensuring that all intervention studies—randomised or observational—maintain the transparency necessary for evidence-based healthcare.
Read the full article on GMJ Newsroom.
Was this article helpful?
